NO20074576L - Radiolabeled Gallium Complexes, Methods for Synthesis and Use For Pet Imaging of EGFR Expression in Malignant Tumors - Google Patents
Radiolabeled Gallium Complexes, Methods for Synthesis and Use For Pet Imaging of EGFR Expression in Malignant TumorsInfo
- Publication number
- NO20074576L NO20074576L NO20074576A NO20074576A NO20074576L NO 20074576 L NO20074576 L NO 20074576L NO 20074576 A NO20074576 A NO 20074576A NO 20074576 A NO20074576 A NO 20074576A NO 20074576 L NO20074576 L NO 20074576L
- Authority
- NO
- Norway
- Prior art keywords
- synthesis
- methods
- malignant tumors
- pet imaging
- egfr expression
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 title abstract 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 title abstract 2
- 238000003384 imaging method Methods 0.000 title abstract 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000002258 gallium Chemical class 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 abstract 2
- 229910052733 gallium Inorganic materials 0.000 abstract 2
- 238000002600 positron emission tomography Methods 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002018 overexpression Effects 0.000 abstract 1
- 229940121896 radiopharmaceutical Drugs 0.000 abstract 1
- 239000012217 radiopharmaceutical Substances 0.000 abstract 1
- 230000002799 radiopharmaceutical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Oppfinnelsen beskriver framgangsmåter for framstilling av radioaktivt merket galliumkompleks ved mikrobølgeaktivering. De resulterende galliumisotopmerkede forbindelsene kan brukes som radiofarmaka, mer spesifikt i positronemisjonstomografi (PET). Det beskrives også en framgangsmåte for å avbilde overekspresjon av EGFR i svulster med PET.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65513905P | 2005-02-22 | 2005-02-22 | |
| PCT/IB2006/000345 WO2006090232A2 (en) | 2005-02-22 | 2006-02-21 | Radiolabeled gallium complexes, methods for synthesis and use for pet imaging of egfr epxression in malignant tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20074576L true NO20074576L (no) | 2007-11-20 |
Family
ID=36927800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20074576A NO20074576L (no) | 2005-02-22 | 2007-09-10 | Radiolabeled Gallium Complexes, Methods for Synthesis and Use For Pet Imaging of EGFR Expression in Malignant Tumors |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20060188441A1 (no) |
| EP (1) | EP1850881A2 (no) |
| JP (1) | JP2008531988A (no) |
| KR (1) | KR20070106731A (no) |
| CN (1) | CN101443051A (no) |
| AU (1) | AU2006217612A1 (no) |
| BR (1) | BRPI0608217A2 (no) |
| CA (1) | CA2598863A1 (no) |
| MX (1) | MX2007010116A (no) |
| NO (1) | NO20074576L (no) |
| RU (1) | RU2007131538A (no) |
| WO (1) | WO2006090232A2 (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8926945B2 (en) * | 2005-10-07 | 2015-01-06 | Guerbet | Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium |
| FR2899585B1 (fr) * | 2006-04-05 | 2012-06-15 | Guerbet Sa | Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium |
| FR2980193B1 (fr) * | 2011-09-15 | 2014-02-14 | Guerbet Sa | Procede de purification de produits de contraste |
| JP6185262B2 (ja) * | 2013-03-07 | 2017-08-23 | 日本メジフィジックス株式会社 | 核医学骨画像解析技術 |
| GB201405591D0 (en) * | 2014-03-28 | 2014-05-14 | Ge Healthcare Ltd | Heatseal |
| CN107405538B (zh) * | 2015-01-30 | 2021-06-15 | 高级催化剂应用品国际有限公司 | 用于从来源于68Ge/68Ga发生器的洗脱物纯化Ga-68的工艺和用于所述工艺中的色谱柱 |
| WO2021234741A1 (en) | 2020-05-18 | 2021-11-25 | C.M.S. S.P.A. | Microwave device for the rapid labelling of in kit-formulated radiopharmaceuticals |
| JP2023157161A (ja) * | 2022-04-14 | 2023-10-26 | 三菱重工航空エンジン株式会社 | 遮熱コーティングの施工方法及び耐熱部材 |
| US20250289832A1 (en) * | 2022-04-27 | 2025-09-18 | Nihon Medi-Physics Co., Ltd. | Method for producing radioactive metal complex |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4288424A (en) * | 1979-01-15 | 1981-09-08 | Massachusetts Institute Of Technology | Generator for ionic gallium-68 based on column chromatography |
| US4330507A (en) * | 1980-06-11 | 1982-05-18 | New England Nuclear Corporation | Method and system for generating and collecting gallium-68 using alkaline eluant |
| DK0436005T3 (da) * | 1989-07-20 | 1995-07-03 | Sandoz Ltd | Mærkede polypeptidderivater |
| US5686410A (en) * | 1989-07-20 | 1997-11-11 | Novartis Ag | Polypeptide derivatives |
| WO1993009816A1 (en) * | 1991-11-14 | 1993-05-27 | Battelle Memorial Institute | Method for diagnosing and treating cancer |
| DE4231622C2 (de) * | 1992-09-22 | 1996-09-05 | Bakelite Ag | Verfahren zur Herstellung von Metallneutralkomplexen mit hoher Koordinationszahl und deren Verwendung |
| US6071490A (en) * | 1998-05-07 | 2000-06-06 | Immunomedics, Inc. | Position emission tomography using gallium-68 chelates |
| EP1389090A2 (en) * | 2001-04-26 | 2004-02-18 | Board of Regents, The University of Texas System | Diagnostic imaging compositions, their methods of synthesis and use |
| GB0308408D0 (en) * | 2003-04-11 | 2003-05-21 | Amersham Plc | Microwave activation |
| WO2004096254A2 (en) * | 2003-05-02 | 2004-11-11 | Xpression Antibody Therapeutics, Inc. | Transferrin conjugates for tumor treatment |
| US20050085417A1 (en) * | 2003-10-16 | 2005-04-21 | Thomas Jefferson University | Compounds and methods for diagnostic imaging and therapy |
-
2006
- 2006-02-21 WO PCT/IB2006/000345 patent/WO2006090232A2/en not_active Ceased
- 2006-02-21 EP EP06710418A patent/EP1850881A2/en not_active Withdrawn
- 2006-02-21 CA CA002598863A patent/CA2598863A1/en not_active Abandoned
- 2006-02-21 KR KR1020077019093A patent/KR20070106731A/ko not_active Withdrawn
- 2006-02-21 RU RU2007131538/15A patent/RU2007131538A/ru unknown
- 2006-02-21 US US11/358,681 patent/US20060188441A1/en not_active Abandoned
- 2006-02-21 BR BRPI0608217A patent/BRPI0608217A2/pt not_active IP Right Cessation
- 2006-02-21 AU AU2006217612A patent/AU2006217612A1/en not_active Abandoned
- 2006-02-21 CN CNA2006800056439A patent/CN101443051A/zh active Pending
- 2006-02-21 JP JP2007555725A patent/JP2008531988A/ja active Pending
- 2006-02-21 MX MX2007010116A patent/MX2007010116A/es unknown
-
2007
- 2007-09-10 NO NO20074576A patent/NO20074576L/no not_active Application Discontinuation
-
2011
- 2011-01-21 US US13/010,870 patent/US20110117012A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006090232A3 (en) | 2007-04-05 |
| CA2598863A1 (en) | 2006-08-31 |
| AU2006217612A1 (en) | 2006-08-31 |
| KR20070106731A (ko) | 2007-11-05 |
| BRPI0608217A2 (pt) | 2016-10-11 |
| MX2007010116A (es) | 2007-10-12 |
| US20060188441A1 (en) | 2006-08-24 |
| CN101443051A (zh) | 2009-05-27 |
| RU2007131538A (ru) | 2009-03-27 |
| EP1850881A2 (en) | 2007-11-07 |
| WO2006090232A2 (en) | 2006-08-31 |
| US20110117012A1 (en) | 2011-05-19 |
| JP2008531988A (ja) | 2008-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074576L (no) | Radiolabeled Gallium Complexes, Methods for Synthesis and Use For Pet Imaging of EGFR Expression in Malignant Tumors | |
| WO2008045604A3 (en) | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications | |
| ATE541571T1 (de) | Diarylhydantoin-verbindung | |
| NZ590923A (en) | Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment | |
| AU2003205077A1 (en) | Imaging agents and methods of imaging naaladase of psma | |
| BG108497A (en) | Solid-phase nucleophilic fluorination | |
| WO2005123993A8 (en) | Phage microarray profiling of the humoral response to disease | |
| WO2009052970A3 (en) | Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors | |
| BR0306715A (pt) | Métodos para diagnóstico e tratamento de tumores | |
| WO2010039609A3 (en) | Conjugates of hexose and metal coordinating compounds for imaging purposes | |
| MX2011010295A (es) | Reactivos de radiomarcado y metodos. | |
| GB0308408D0 (en) | Microwave activation | |
| WO2008024826A3 (en) | Radiohalothymidines and methods of their synthesis and use in pet imaging of cancers | |
| TW200738271A (en) | Methods of making radiolabeled tracers and precursors thereof | |
| WO2007056049A3 (en) | Molecular profiling of cancer | |
| WO2007033167A3 (en) | Compositions and methods for detecting and treating cancer | |
| WO2008026051A3 (en) | 68ga-labelling of a free and macromolecule conjugated macrocyclic chelator at ambient temperature | |
| WO2006052975A3 (en) | Tumor association of mdl-1 and methods | |
| EA200800948A1 (ru) | Биотиндиаминопроизводные и их конъюгаты с макроциклическими хелатирующими реагентами | |
| ITMC20050119A1 (it) | SINTESI CHIMICA DI (RAMEDEOSSIGLUCOSIO;[64Cu] TETA-DEOSSIGLUCOSIO), E UTILIZZO DELLO STESSO COME AGENTE PER INDAGINI PET (POSITRON EMISSION TOMOGRAPHY IMAGING) E PER LA RADIOTERAPIA. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |